ORTHOCELL LIMITED — Director's Dealing 2024

Oct 14, 2024

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Introduced 30/9/2001.
Name of entity	Orthocell Limited
ABN	57 118 897 135

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

director for the purposes of section	205G of the Corporations Act.
Name of Director	Paul Anderson
Date of last notice	7 November 2023

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Direct and Indirect
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	Mr Anderson is a trustee and beneficiary of the Elwing Superannuation Fund Nicole Telford – spouse
Date of change	15 October 2024
No. of securities held prior to change Paul Anderson & Nicole Telford Paul Anderson Nicole Telford Paul Anderson & Nicole Telford Fund>	6,233,335 Ordinary Shares 16 Ordinary Shares 4,000,000 Unlisted Options exercisable at $0.583 expiring 14 October 2024 1,200,000 Unlisted Options exercisable at $0.583 expiring 14 October 2024 500,000 Unlisted Options exercisable at $0.36 expiring 7 November 2023 670,454 Ordinary Shares
Class	Ordinary Shares Unlisted Options exercisable at $0.583 expiring 14 October 2024
Number acquired	268,089 Ordinary Shares – Mr Anderson 80,426 OrdinaryShares – Ms Telford
Number disposed	4,000,000 Unlisted Options exercisable at $0.583 expiring 14 October 2024 – Mr Anderson 1,200,000 Unlisted Options exercisable at $0.583 expiring 14 October 2024 – Ms Telford

• See chapter 19 for defined terms.

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	Cashless exercise of Unlisted Options.
No. of securities held after change Paul Anderson and Nicole Telford Paul Anderson Nicole Telford Paul Anderson and Nicole Telford Fund>	6,233,335 Ordinary Shares 268,105 Ordinary Shares 80,426 Ordinary Shares 500,000 Unlisted Options exercisable at $0.36 expiring 7 November 2023 670,454 Ordinary Shares
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy- back	Cashless exercise of 4,000,000 Unlisted Options exercisable at $0.583 expiring 14 October 2024 by Mr Anderson and cashless exercise of 1,2000,000 Unlisted Options exercisable at $0.583 expiring 14 October 2024 by Ms Telford

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest	N/A
Name of registered holder (if issued securities)	N/A
Date of change	N/A
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed	N/A
Interest acquired	N/A
Interest disposed	N/A
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation	N/A
Interest after change	N/A

Part 3 Closed Period

Part 3 Closed Period
Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required?	N/A
If so, was prior written clearance provided to allow the trade to proceed during this period?	N/A
If prior written clearance was provided, on what date was this provided?	N/A

• See chapter 19 for defined terms.

Appendix 3Y Page 2